Your browser doesn't support javascript.
loading
[MSI-high ascending colon cancer treated with second-line ipilimumab plus nivolumab for conversion surgery:a case report].
Kodama, Tomoko; Nakazawa, Junichi; Kawahira, Masahiro; Hori, Takeshi; Motoi, Shunsuke; Yanagi, Masayuki; Hamada, Nobuo; Sueyoshi, Kazuyoshi; Tsubouchi, Hirohito; Ido, Akio.
Affiliation
  • Kodama T; Department of Oncology, Kagoshima-city Hospital.
  • Nakazawa J; Department of Oncology, Kagoshima-city Hospital.
  • Kawahira M; Department of Oncology, Kagoshima-city Hospital.
  • Hori T; Department of Gastroenterology and Hepatology, Kagoshima-city Hospital.
  • Motoi S; Department of Gastroenterological Surgery, Kagoshima-city Hospital.
  • Yanagi M; Department of Gastroenterological Surgery, Kagoshima-city Hospital.
  • Hamada N; Department of Gastroenterological Surgery, Kagoshima-city Hospital.
  • Sueyoshi K; Department of Pathology, Kagoshima-city Hospital.
  • Tsubouchi H; Department of Gastroenterology and Hepatology, Kagoshima-city Hospital.
  • Ido A; Department of Digestive Disease and Lifestyle-related Diseases, Kagoshima University Hospital.
Nihon Shokakibyo Gakkai Zasshi ; 120(3): 256-262, 2023.
Article in Ja | MEDLINE | ID: mdl-36908144
ABSTRACT
A 68-year-old woman with ascending colon cancer was the patient (cT4bN2M1a [LYM] cStage IVA, BRAF V600E mutation-positive, and MSI-high). She was given modified FOLFOXIRI as first-line therapy but did not respond. The infiltration of the primary lesion in the abdominal wall was alleviated, allowing conversion surgery to be performed.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Colonic Neoplasms / Nivolumab Limits: Aged / Female / Humans Language: Ja Journal: Nihon Shokakibyo Gakkai Zasshi Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Colonic Neoplasms / Nivolumab Limits: Aged / Female / Humans Language: Ja Journal: Nihon Shokakibyo Gakkai Zasshi Year: 2023 Type: Article